Insider transactions

EDGAR

Cognition Therapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
3 transactions, 29,175 shares
Sum of shares × price per share: 32,492.5
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–26 of 26

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-06-17 Filed 2026-06-22Wallace Peggy Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)25,0000.00
0

Derived: shares × price per share. Exact value 0.00.

111,461Direct (D) No
F1
  • F1 Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.
Open filing 0001104659-26-076472 Read from the filing’s XML Dispute this row
2026-06-17 Filed 2026-06-22Khattar Jack A. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)25,0000.00
0

Derived: shares × price per share. Exact value 0.00.

73,500Direct (D) No
F1
  • F1 Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.
Open filing 0001104659-26-076477 Read from the filing’s XML Dispute this row
2026-06-17 Filed 2026-06-22RICHSTONE ELLEN B Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)25,0000.00
0

Derived: shares × price per share. Exact value 0.00.

83,500Direct (D) No
F1
  • F1 Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.
Open filing 0001104659-26-076470 Read from the filing’s XML Dispute this row
2026-06-17 Filed 2026-06-22Monia Brett P Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)25,0000.00
0

Derived: shares × price per share. Exact value 0.00.

73,500Direct (D) No
F1
  • F1 Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.
Open filing 0001104659-26-076475 Read from the filing’s XML Dispute this row
2026-06-17 Filed 2026-06-22Fletcher Aaron G.L. Director · 10% ownerBIOS Capital Management, LP Director · 10% ownerBIOS Advisors GP, LLC Director · 10% ownerBios Equity Partners, LP Director · 10% ownerBIOS Fund I, LP Director · 10% ownerBIOS Fund II QP, LP Director · 10% ownerBIOS Memory SPV I, LP Director · 10% ownerBios Equity Partners II, LP Director · 10% ownerBIOS Fund II, LP Director · 10% ownerBIOS Fund I QP, LP Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)25,0000—81,229Direct (D) No
F1, F2
  • F1 Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.
  • F2 Pursuant to an agreement with BP Directors, LP (Bios Directors), Dr. Fletcher has agreed that he will hold certain equity-based awards granted to him in connection with his services as a director of the Issuer merely as a nominee for Bios Directors. Bios Directors may be deemed the direct or indirect beneficial owner of the reported securities, and Bios Equity Partners, LP (Bios Equity I), Cavu Management, LP (Cavu Management), Bios Capital Management, LP (Bios Management), Cavu Advisors LLC (Cavu Advisors), Bios Advisors GP, LLC (Bios Advisors), Leslie W. Kreis, Jr. (Mr. Kreis) and Dr. Fletcher may each be deemed the indirect beneficial owner of the reported securities through his or its respective indirect interest in Bios Directors.
Open filing 0001789490-26-000002 Read from the filing’s XML Dispute this row
2026-05-01 Filed 2026-05-04Doyle John Brendan Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)8,5671.28
10,965.76

Derived: shares × price per share. Exact value 10965.76.

618,942Direct (D) No
F1
  • F1 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units.
Open filing 0001104659-26-054858 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-20Doyle John Brendan Officer: Chief Financial Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)10,0001.13
11,300

Derived: shares × price per share. Exact value 11300.00.

627,509Direct (D) No— Open filing 0001104659-26-045511 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-20Caggiano Anthony Officer: Chief Medical Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)10,0001.11
11,100

Derived: shares × price per share. Exact value 11100.00.

874,906Direct (D) No— Open filing 0001104659-26-045499 Read from the filing’s XML Dispute this row
2026-04-16 Filed 2026-04-20Ricciardi Lisa Director · Officer: CEO President
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)9,1751.10
10,092.5

Derived: shares × price per share. Exact value 10092.50.

1,715,851Direct (D) No— Open filing 0001104659-26-045502 Read from the filing’s XML Dispute this row
2026-02-15 Filed 2026-02-18Ricciardi Lisa Director · Officer: CEO President
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)5,8501.12
6,552

Derived: shares × price per share. Exact value 6552.00.

1,706,676Direct (D) No
F1
  • F1 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units.
Open filing 0001104659-26-017070 Read from the filing’s XML Dispute this row
2026-02-15 Filed 2026-02-18Doyle John Brendan Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1,5601.12
1,747.2

Derived: shares × price per share. Exact value 1747.20.

617,509Direct (D) No
F1
  • F1 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units.
Open filing 0001104659-26-017068 Read from the filing’s XML Dispute this row
2026-02-15 Filed 2026-02-18Caggiano Anthony Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)4,6801.12
5,241.6

Derived: shares × price per share. Exact value 5241.60.

864,906Direct (D) No
F1
  • F1 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted stock units.
Open filing 0001104659-26-017063 Read from the filing’s XML Dispute this row
2026-02-04 Filed 2026-02-05Doyle John Brendan Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)26,9211.03
27,728.63

Derived: shares × price per share. Exact value 27728.63.

619,069Direct (D) No
F2
  • F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001104659-26-011074 Read from the filing’s XML Dispute this row
2026-02-04 Filed 2026-02-05Ricciardi Lisa Director · Officer: CEO President
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)51,7041.03
53,255.12

Derived: shares × price per share. Exact value 53255.12.

1,712,526Direct (D) No
F2
  • F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001104659-26-011075 Read from the filing’s XML Dispute this row
2026-02-04 Filed 2026-02-05Caggiano Anthony Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)26,9191.03
27,726.57

Derived: shares × price per share. Exact value 27726.57.

869,586Direct (D) No
F2
  • F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001104659-26-011073 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Doyle John Brendan Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)200,0000.00
0

Derived: shares × price per share. Exact value 0.00.

645,990Direct (D) No
F1
  • F1 Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
Open filing 0001104659-26-011074 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Ricciardi Lisa Director · Officer: CEO President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)800,0000.00
0

Derived: shares × price per share. Exact value 0.00.

1,790,266Direct (D) No
F1
  • F1 Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
Open filing 0001104659-26-011075 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Ricciardi Lisa Director · Officer: CEO President
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)26,0361.12
29,160.32

Derived: shares × price per share. Exact value 29160.32.

1,764,230Direct (D) No
F2
  • F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001104659-26-011075 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Caggiano Anthony Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)400,0000.00
0

Derived: shares × price per share. Exact value 0.00.

907,993Direct (D) No
F1
  • F1 Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
Open filing 0001104659-26-011073 Read from the filing’s XML Dispute this row
2026-02-03 Filed 2026-02-05Caggiano Anthony Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)11,4881.12
12,866.56

Derived: shares × price per share. Exact value 12866.56.

896,505Direct (D) No
F2
  • F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
Open filing 0001104659-26-011073 Read from the filing’s XML Dispute this row
2025-12-18 Filed 2025-12-22Ricciardi Lisa Director · Officer: CEO President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)75,0000.00
0

Derived: shares × price per share. Exact value 0.00.

1,013,666Direct (D) No
F1
  • F1 Shares earned upon the vesting of performance stock units (PSUs) granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. The remaining 50% of the total number of shares subject to the PSUs vested on December 18, 2025.
Open filing 0001104659-25-123727 Read from the filing’s XML Dispute this row
2025-12-18 Filed 2025-12-22Ricciardi Lisa Director · Officer: CEO President
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)23,4001.50
35,100

Derived: shares × price per share. Exact value 35100.00.

990,266Direct (D) No
F2
  • F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs.
Open filing 0001104659-25-123727 Read from the filing’s XML Dispute this row
2025-12-18 Filed 2025-12-22Caggiano Anthony Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)65,0000.00
0

Derived: shares × price per share. Exact value 0.00.

528,273Direct (D) No
F1
  • F1 Shares earned upon the vesting of performance stock units (PSUs) granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. The remaining 50% of the total number of shares subject to the PSUs vested on December 18, 2025.
Open filing 0001104659-25-123722 Read from the filing’s XML Dispute this row
2025-12-18 Filed 2025-12-22Caggiano Anthony Officer: Chief Medical Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)20,2801.50
30,420

Derived: shares × price per share. Exact value 30420.00.

507,993Direct (D) No
F2
  • F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs.
Open filing 0001104659-25-123722 Read from the filing’s XML Dispute this row
2025-12-18 Filed 2025-12-22Doyle John Brendan Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)30,0000.00
0

Derived: shares × price per share. Exact value 0.00.

455,350Direct (D) No
F1
  • F1 Shares earned upon the vesting of performance stock units (PSUs) granted to the Reporting Person on February 14, 2024. Each PSU represents a contingent right to receive one share of the Issuer's Common Stock upon the achievement of certain performance goals. The remaining 50% of the total number of shares subject to the PSUs vested on December 18, 2025.
Open filing 0001104659-25-123721 Read from the filing’s XML Dispute this row
2025-12-18 Filed 2025-12-22Doyle John Brendan Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)9,3601.50
14,040

Derived: shares × price per share. Exact value 14040.00.

445,990Direct (D) No
F2
  • F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of PSUs.
Open filing 0001104659-25-123721 Read from the filing’s XML Dispute this row

Latest reported holdings

What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.

Latest reported holdings
Reporting ownerSecurityShares owned afterDirect or indirectSource
BIOS Advisors GP, LLC Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2026-06-22 Open filing 4
BIOS Advisors GP, LLC Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2026-06-22 Open filing 4
BIOS Advisors GP, LLC Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2026-06-22 Open filing 4
BIOS Advisors GP, LLC Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2026-06-22 Open filing 4
BIOS Advisors GP, LLC Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2026-06-22 Open filing 4
BIOS Advisors GP, LLC Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2026-06-22 Open filing 4
BIOS Advisors GP, LLC Director · 10% ownerCommon Stock 326,732I By Bios Fund III NT, LPAs of 2026-06-22 Open filing 4
BIOS Advisors GP, LLC Director · 10% ownerCommon Stock 2,021,907I By Bios Fund III QP, LPAs of 2026-06-22 Open filing 4
BIOS Advisors GP, LLC Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2026-06-22 Open filing 4
BIOS Advisors GP, LLC Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2026-06-22 Open filing 4
BIOS Advisors GP, LLC Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2026-06-22 Open filing 4
BIOS Advisors GP, LLC Director · 10% ownerCommon Stock 81,229D As of 2026-06-17 Open filing 4
BIOS Capital Management, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2026-06-22 Open filing 4
BIOS Capital Management, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2026-06-22 Open filing 4
BIOS Capital Management, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2026-06-22 Open filing 4
BIOS Capital Management, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2026-06-22 Open filing 4
BIOS Capital Management, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2026-06-22 Open filing 4
BIOS Capital Management, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2026-06-22 Open filing 4
BIOS Capital Management, LP Director · 10% ownerCommon Stock 326,732I By Bios Fund III NT, LPAs of 2026-06-22 Open filing 4
BIOS Capital Management, LP Director · 10% ownerCommon Stock 2,021,907I By Bios Fund III QP, LPAs of 2026-06-22 Open filing 4
BIOS Capital Management, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2026-06-22 Open filing 4
BIOS Capital Management, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2026-06-22 Open filing 4
BIOS Capital Management, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2026-06-22 Open filing 4
BIOS Capital Management, LP Director · 10% ownerCommon Stock 81,229D As of 2026-06-17 Open filing 4
BIOS Equity Partners III, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2025-06-20 Open filing 4
BIOS Equity Partners III, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2025-06-20 Open filing 4
BIOS Equity Partners III, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2025-06-20 Open filing 4
BIOS Equity Partners III, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2025-06-20 Open filing 4
BIOS Equity Partners III, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2025-06-20 Open filing 4
BIOS Equity Partners III, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2025-06-20 Open filing 4
BIOS Equity Partners III, LP Director · 10% ownerCommon Stock 326,733I By Bios Fund III NT, LPAs of 2025-06-20 Open filing 4
BIOS Equity Partners III, LP Director · 10% ownerCommon Stock 2,021,906I By Bios Fund III QP, LPAs of 2025-06-20 Open filing 4
BIOS Equity Partners III, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2025-06-20 Open filing 4
BIOS Equity Partners III, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2025-06-20 Open filing 4
BIOS Equity Partners III, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2025-06-20 Open filing 4
BIOS Equity Partners III, LP Director · 10% ownerCommon Stock 48,500I See FootnoteAs of 2025-06-18 Open filing 4
BIOS Fund I QP, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2026-06-22 Open filing 4
BIOS Fund I QP, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2026-06-22 Open filing 4
BIOS Fund I QP, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2026-06-22 Open filing 4
BIOS Fund I QP, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2026-06-22 Open filing 4
BIOS Fund I QP, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2026-06-22 Open filing 4
BIOS Fund I QP, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2026-06-22 Open filing 4
BIOS Fund I QP, LP Director · 10% ownerCommon Stock 326,732I By Bios Fund III NT, LPAs of 2026-06-22 Open filing 4
BIOS Fund I QP, LP Director · 10% ownerCommon Stock 2,021,907I By Bios Fund III QP, LPAs of 2026-06-22 Open filing 4
BIOS Fund I QP, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2026-06-22 Open filing 4
BIOS Fund I QP, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2026-06-22 Open filing 4
BIOS Fund I QP, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2026-06-22 Open filing 4
BIOS Fund I QP, LP Director · 10% ownerCommon Stock 81,229D As of 2026-06-17 Open filing 4
BIOS Fund I, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2026-06-22 Open filing 4
BIOS Fund I, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2026-06-22 Open filing 4
BIOS Fund I, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2026-06-22 Open filing 4
BIOS Fund I, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2026-06-22 Open filing 4
BIOS Fund I, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2026-06-22 Open filing 4
BIOS Fund I, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2026-06-22 Open filing 4
BIOS Fund I, LP Director · 10% ownerCommon Stock 326,732I By Bios Fund III NT, LPAs of 2026-06-22 Open filing 4
BIOS Fund I, LP Director · 10% ownerCommon Stock 2,021,907I By Bios Fund III QP, LPAs of 2026-06-22 Open filing 4
BIOS Fund I, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2026-06-22 Open filing 4
BIOS Fund I, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2026-06-22 Open filing 4
BIOS Fund I, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2026-06-22 Open filing 4
BIOS Fund I, LP Director · 10% ownerCommon Stock 81,229D As of 2026-06-17 Open filing 4
BIOS Fund II NT, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2025-06-20 Open filing 4
BIOS Fund II NT, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2025-06-20 Open filing 4
BIOS Fund II NT, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2025-06-20 Open filing 4
BIOS Fund II NT, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2025-06-20 Open filing 4
BIOS Fund II NT, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2025-06-20 Open filing 4
BIOS Fund II NT, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2025-06-20 Open filing 4
BIOS Fund II NT, LP Director · 10% ownerCommon Stock 326,733I By Bios Fund III NT, LPAs of 2025-06-20 Open filing 4
BIOS Fund II NT, LP Director · 10% ownerCommon Stock 2,021,906I By Bios Fund III QP, LPAs of 2025-06-20 Open filing 4
BIOS Fund II NT, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2025-06-20 Open filing 4
BIOS Fund II NT, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2025-06-20 Open filing 4
BIOS Fund II NT, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2025-06-20 Open filing 4
BIOS Fund II NT, LP Director · 10% ownerCommon Stock 48,500I See FootnoteAs of 2025-06-18 Open filing 4
BIOS Fund II QP, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2026-06-22 Open filing 4
BIOS Fund II QP, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2026-06-22 Open filing 4
BIOS Fund II QP, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2026-06-22 Open filing 4
BIOS Fund II QP, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2026-06-22 Open filing 4
BIOS Fund II QP, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2026-06-22 Open filing 4
BIOS Fund II QP, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2026-06-22 Open filing 4
BIOS Fund II QP, LP Director · 10% ownerCommon Stock 326,732I By Bios Fund III NT, LPAs of 2026-06-22 Open filing 4
BIOS Fund II QP, LP Director · 10% ownerCommon Stock 2,021,907I By Bios Fund III QP, LPAs of 2026-06-22 Open filing 4
BIOS Fund II QP, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2026-06-22 Open filing 4
BIOS Fund II QP, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2026-06-22 Open filing 4
BIOS Fund II QP, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2026-06-22 Open filing 4
BIOS Fund II QP, LP Director · 10% ownerCommon Stock 81,229D As of 2026-06-17 Open filing 4
BIOS Fund II, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2026-06-22 Open filing 4
BIOS Fund II, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2026-06-22 Open filing 4
BIOS Fund II, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2026-06-22 Open filing 4
BIOS Fund II, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2026-06-22 Open filing 4
BIOS Fund II, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2026-06-22 Open filing 4
BIOS Fund II, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2026-06-22 Open filing 4
BIOS Fund II, LP Director · 10% ownerCommon Stock 326,732I By Bios Fund III NT, LPAs of 2026-06-22 Open filing 4
BIOS Fund II, LP Director · 10% ownerCommon Stock 2,021,907I By Bios Fund III QP, LPAs of 2026-06-22 Open filing 4
BIOS Fund II, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2026-06-22 Open filing 4
BIOS Fund II, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2026-06-22 Open filing 4
BIOS Fund II, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2026-06-22 Open filing 4
BIOS Fund II, LP Director · 10% ownerCommon Stock 81,229D As of 2026-06-17 Open filing 4
BIOS Fund III NT, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2025-06-20 Open filing 4
BIOS Fund III NT, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2025-06-20 Open filing 4
BIOS Fund III NT, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2025-06-20 Open filing 4
BIOS Fund III NT, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2025-06-20 Open filing 4
BIOS Fund III NT, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2025-06-20 Open filing 4
BIOS Fund III NT, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2025-06-20 Open filing 4
BIOS Fund III NT, LP Director · 10% ownerCommon Stock 326,733I By Bios Fund III NT, LPAs of 2025-06-20 Open filing 4
BIOS Fund III NT, LP Director · 10% ownerCommon Stock 2,021,906I By Bios Fund III QP, LPAs of 2025-06-20 Open filing 4
BIOS Fund III NT, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2025-06-20 Open filing 4
BIOS Fund III NT, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2025-06-20 Open filing 4
BIOS Fund III NT, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2025-06-20 Open filing 4
BIOS Fund III NT, LP Director · 10% ownerCommon Stock 48,500I See FootnoteAs of 2025-06-18 Open filing 4
BIOS Fund III QP, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2025-06-20 Open filing 4
BIOS Fund III QP, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2025-06-20 Open filing 4
BIOS Fund III QP, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2025-06-20 Open filing 4
BIOS Fund III QP, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2025-06-20 Open filing 4
BIOS Fund III QP, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2025-06-20 Open filing 4
BIOS Fund III QP, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2025-06-20 Open filing 4
BIOS Fund III QP, LP Director · 10% ownerCommon Stock 326,733I By Bios Fund III NT, LPAs of 2025-06-20 Open filing 4
BIOS Fund III QP, LP Director · 10% ownerCommon Stock 2,021,906I By Bios Fund III QP, LPAs of 2025-06-20 Open filing 4
BIOS Fund III QP, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2025-06-20 Open filing 4
BIOS Fund III QP, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2025-06-20 Open filing 4
BIOS Fund III QP, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2025-06-20 Open filing 4
BIOS Fund III QP, LP Director · 10% ownerCommon Stock 48,500I See FootnoteAs of 2025-06-18 Open filing 4
BIOS Fund III, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2025-06-20 Open filing 4
BIOS Fund III, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2025-06-20 Open filing 4
BIOS Fund III, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2025-06-20 Open filing 4
BIOS Fund III, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2025-06-20 Open filing 4
BIOS Fund III, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2025-06-20 Open filing 4
BIOS Fund III, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2025-06-20 Open filing 4
BIOS Fund III, LP Director · 10% ownerCommon Stock 326,733I By Bios Fund III NT, LPAs of 2025-06-20 Open filing 4
BIOS Fund III, LP Director · 10% ownerCommon Stock 2,021,906I By Bios Fund III QP, LPAs of 2025-06-20 Open filing 4
BIOS Fund III, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2025-06-20 Open filing 4
BIOS Fund III, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2025-06-20 Open filing 4
BIOS Fund III, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2025-06-20 Open filing 4
BIOS Fund III, LP Director · 10% ownerCommon Stock 48,500I See FootnoteAs of 2025-06-18 Open filing 4
BIOS Memory SPV I, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2026-06-22 Open filing 4
BIOS Memory SPV I, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2026-06-22 Open filing 4
BIOS Memory SPV I, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2026-06-22 Open filing 4
BIOS Memory SPV I, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2026-06-22 Open filing 4
BIOS Memory SPV I, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2026-06-22 Open filing 4
BIOS Memory SPV I, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2026-06-22 Open filing 4
BIOS Memory SPV I, LP Director · 10% ownerCommon Stock 326,732I By Bios Fund III NT, LPAs of 2026-06-22 Open filing 4
BIOS Memory SPV I, LP Director · 10% ownerCommon Stock 2,021,907I By Bios Fund III QP, LPAs of 2026-06-22 Open filing 4
BIOS Memory SPV I, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2026-06-22 Open filing 4
BIOS Memory SPV I, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2026-06-22 Open filing 4
BIOS Memory SPV I, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2026-06-22 Open filing 4
BIOS Memory SPV I, LP Director · 10% ownerCommon Stock 81,229D As of 2026-06-17 Open filing 4
BIOS Memory SPV II, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2025-06-20 Open filing 4
BIOS Memory SPV II, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2025-06-20 Open filing 4
BIOS Memory SPV II, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2025-06-20 Open filing 4
BIOS Memory SPV II, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2025-06-20 Open filing 4
BIOS Memory SPV II, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2025-06-20 Open filing 4
BIOS Memory SPV II, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2025-06-20 Open filing 4
BIOS Memory SPV II, LP Director · 10% ownerCommon Stock 326,733I By Bios Fund III NT, LPAs of 2025-06-20 Open filing 4
BIOS Memory SPV II, LP Director · 10% ownerCommon Stock 2,021,906I By Bios Fund III QP, LPAs of 2025-06-20 Open filing 4
BIOS Memory SPV II, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2025-06-20 Open filing 4
BIOS Memory SPV II, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2025-06-20 Open filing 4
BIOS Memory SPV II, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2025-06-20 Open filing 4
BIOS Memory SPV II, LP Director · 10% ownerCommon Stock 48,500I See FootnoteAs of 2025-06-18 Open filing 4
BP Directors, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2025-06-20 Open filing 4
BP Directors, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2025-06-20 Open filing 4
BP Directors, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2025-06-20 Open filing 4
BP Directors, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2025-06-20 Open filing 4
BP Directors, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2025-06-20 Open filing 4
BP Directors, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2025-06-20 Open filing 4
BP Directors, LP Director · 10% ownerCommon Stock 326,733I By Bios Fund III NT, LPAs of 2025-06-20 Open filing 4
BP Directors, LP Director · 10% ownerCommon Stock 2,021,906I By Bios Fund III QP, LPAs of 2025-06-20 Open filing 4
BP Directors, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2025-06-20 Open filing 4
BP Directors, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2025-06-20 Open filing 4
BP Directors, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2025-06-20 Open filing 4
BP Directors, LP Director · 10% ownerCommon Stock 48,500I See FootnoteAs of 2025-06-18 Open filing 4
Bios Equity Partners II, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners II, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners II, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners II, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners II, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners II, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners II, LP Director · 10% ownerCommon Stock 326,732I By Bios Fund III NT, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners II, LP Director · 10% ownerCommon Stock 2,021,907I By Bios Fund III QP, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners II, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners II, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners II, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners II, LP Director · 10% ownerCommon Stock 81,229D As of 2026-06-17 Open filing 4
Bios Equity Partners, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners, LP Director · 10% ownerCommon Stock 326,732I By Bios Fund III NT, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners, LP Director · 10% ownerCommon Stock 2,021,907I By Bios Fund III QP, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2026-06-22 Open filing 4
Bios Equity Partners, LP Director · 10% ownerCommon Stock 81,229D As of 2026-06-17 Open filing 4
Caggiano Anthony Officer: Chief Medical OfficerCommon Stock 874,906D As of 2026-04-16 Open filing 4
Cavu Advisors, LLC Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2025-06-20 Open filing 4
Cavu Advisors, LLC Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2025-06-20 Open filing 4
Cavu Advisors, LLC Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2025-06-20 Open filing 4
Cavu Advisors, LLC Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2025-06-20 Open filing 4
Cavu Advisors, LLC Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2025-06-20 Open filing 4
Cavu Advisors, LLC Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2025-06-20 Open filing 4
Cavu Advisors, LLC Director · 10% ownerCommon Stock 326,733I By Bios Fund III NT, LPAs of 2025-06-20 Open filing 4
Cavu Advisors, LLC Director · 10% ownerCommon Stock 2,021,906I By Bios Fund III QP, LPAs of 2025-06-20 Open filing 4
Cavu Advisors, LLC Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2025-06-20 Open filing 4
Cavu Advisors, LLC Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2025-06-20 Open filing 4
Cavu Advisors, LLC Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2025-06-20 Open filing 4
Cavu Advisors, LLC Director · 10% ownerCommon Stock 48,500I See FootnoteAs of 2025-06-18 Open filing 4
Cavu Management, LP Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2025-06-20 Open filing 4
Cavu Management, LP Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2025-06-20 Open filing 4
Cavu Management, LP Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2025-06-20 Open filing 4
Cavu Management, LP Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2025-06-20 Open filing 4
Cavu Management, LP Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2025-06-20 Open filing 4
Cavu Management, LP Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2025-06-20 Open filing 4
Cavu Management, LP Director · 10% ownerCommon Stock 326,733I By Bios Fund III NT, LPAs of 2025-06-20 Open filing 4
Cavu Management, LP Director · 10% ownerCommon Stock 2,021,906I By Bios Fund III QP, LPAs of 2025-06-20 Open filing 4
Cavu Management, LP Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2025-06-20 Open filing 4
Cavu Management, LP Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2025-06-20 Open filing 4
Cavu Management, LP Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2025-06-20 Open filing 4
Cavu Management, LP Director · 10% ownerCommon Stock 48,500I See FootnoteAs of 2025-06-18 Open filing 4
Doyle John Brendan Officer: Chief Financial OfficerCommon Stock 618,942D As of 2026-05-01 Open filing 4
Fletcher Aaron G.L. Director · 10% ownerStock Option (right to buy) Derivative security · underlying Common Stock0D As of 2025-09-19 Open filing 4
Fletcher Aaron G.L. Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2026-06-22 Open filing 4
Fletcher Aaron G.L. Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2026-06-22 Open filing 4
Fletcher Aaron G.L. Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2026-06-22 Open filing 4
Fletcher Aaron G.L. Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2026-06-22 Open filing 4
Fletcher Aaron G.L. Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2026-06-22 Open filing 4
Fletcher Aaron G.L. Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2026-06-22 Open filing 4
Fletcher Aaron G.L. Director · 10% ownerCommon Stock 326,732I By Bios Fund III NT, LPAs of 2026-06-22 Open filing 4
Fletcher Aaron G.L. Director · 10% ownerCommon Stock 2,021,907I By Bios Fund III QP, LPAs of 2026-06-22 Open filing 4
Fletcher Aaron G.L. Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2026-06-22 Open filing 4
Fletcher Aaron G.L. Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2026-06-22 Open filing 4
Fletcher Aaron G.L. Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2026-06-22 Open filing 4
Fletcher Aaron G.L. Director · 10% ownerCommon Stock 81,229D As of 2026-06-17 Open filing 4
Khattar Jack A. DirectorCommon Stock 73,500D As of 2026-06-17 Open filing 4
Kreis Leslie W. Director · 10% ownerCommon Stock 500,095I By Bios Clinical Opportunity Fund, LPAs of 2025-06-20 Open filing 4
Kreis Leslie W. Director · 10% ownerCommon Stock 245,029I By Bios Fund I QP, LPAs of 2025-06-20 Open filing 4
Kreis Leslie W. Director · 10% ownerCommon Stock 418,926I By Bios Fund I, LPAs of 2025-06-20 Open filing 4
Kreis Leslie W. Director · 10% ownerCommon Stock 34,238I By Bios Fund II NT, LPAs of 2025-06-20 Open filing 4
Kreis Leslie W. Director · 10% ownerCommon Stock 255,765I By Bios Fund II QP, LPAs of 2025-06-20 Open filing 4
Kreis Leslie W. Director · 10% ownerCommon Stock 78,298I By Bios Fund II, LPAs of 2025-06-20 Open filing 4
Kreis Leslie W. Director · 10% ownerCommon Stock 326,733I By Bios Fund III NT, LPAs of 2025-06-20 Open filing 4
Kreis Leslie W. Director · 10% ownerCommon Stock 2,021,906I By Bios Fund III QP, LPAs of 2025-06-20 Open filing 4
Kreis Leslie W. Director · 10% ownerCommon Stock 309,748I By Bios Fund III, LPAs of 2025-06-20 Open filing 4
Kreis Leslie W. Director · 10% ownerCommon Stock 1,424,014I By Bios Memory SPV I, LPAs of 2025-06-20 Open filing 4
Kreis Leslie W. Director · 10% ownerCommon Stock 385,248I By Bios Memory SPV II, LPAs of 2025-06-20 Open filing 4
Kreis Leslie W. Director · 10% ownerCommon Stock 48,500I See FootnoteAs of 2025-06-18 Open filing 4
Monia Brett P DirectorCommon Stock 73,500D As of 2026-06-17 Open filing 4
RICHSTONE ELLEN B DirectorCommon Stock 83,500D As of 2026-06-17 Open filing 4
Ricciardi Lisa Director · Officer: CEO PresidentCommon Stock 38,851I By SpouseAs of 2026-04-20 Open filing 4
Ricciardi Lisa Director · Officer: CEO PresidentCommon Stock 1,715,851D As of 2026-04-16 Open filing 4
Ricciardi Lisa Director · Officer: CEO PresidentCommon Stock 38,851I By SpouseAs of 2025-01-31 Open filing 4
Wallace Peggy DirectorCommon Stock 111,461D As of 2026-06-17 Open filing 4

Joint filers each report the same shares, so rows are not added together.

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 78

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BIOS Capital Management, LP Partly reported under another manager6,000,000 SH5,760,000 dollarsUnchanged Prior quarter: 6,000,000Open filing 0001813845-26-000009 Filed 2026-11-13 Dispute this row
DAVENPORT Co LLC 4,248,410 SH4,078,474 dollarsLower by 11,101 Prior quarter: 4,259,511Open filing 0000887777-26-000029 Filed 2026-10-14 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 3,438,775 SH3,301,224 dollarsUnchanged Prior quarter: 3,438,775Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
BlackRock, Inc. Partly reported under another manager1,253,474 SH1,203,335 dollarsLower by 8,519 Prior quarter: 1,261,993Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
Chescapmanager LLC Partly reported under another manager997,029 SH957,148 dollarsUnchanged Prior quarter: 997,029Open filing 0001140361-26-043745 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager911,526 SH875,525 dollarsHigher by 1,520 Prior quarter: 910,006Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager587,171 SH563,684 dollarsLower by 106,117 Prior quarter: 693,288Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
Hilton Capital Management, LLC 548,950 SH526,992 dollarsUnchanged Prior quarter: 548,950Open filing 0001172661-26-004953 Filed 2026-11-12 Dispute this row
VANGUARD FIDUCIARY TRUST CO 508,220 SH487,891 dollarsUnchanged Prior quarter: 508,220Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
CM Management, LLC 425,000 SH408,000 dollarsLower by 25,000 Prior quarter: 450,000Open filing 0001841857-26-000004 Filed 2026-11-12 Dispute this row
Sigma Planning Corp 364,765 SH350,174 dollarsHigher by 2,500 Prior quarter: 362,265Open filing 0001420506-26-002366 Filed 2026-10-23 Dispute this row
STATE STREET CORP Partly reported under another manager348,983 SH335,024 dollarsUnchanged Prior quarter: 348,983Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
TOCQUEVILLE ASSET MANAGEMENT L.P. 230,500 SH221,280 dollarsLower by 90,000 Prior quarter: 320,500Open filing 0000919574-26-007782 Filed 2026-11-13 Dispute this row
Dauntless Investment Group, LLC 207,714 SH199,405 dollarsLower by 163,987 Prior quarter: 371,701Open filing 0002071844-26-001894 Filed 2026-11-16 Dispute this row
AMERICAN FINANCIAL GROUP INC Partly reported under another manager205,000 SH196,800 dollarsUnchanged Prior quarter: 205,000Open filing 0001042046-26-000037 Filed 2026-11-12 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager178,202 SH171,074 dollarsUnchanged Prior quarter: 178,202Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager152,114 SH146,029 dollarsNot in the prior quarter’s filings read Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
Texas Capital Bank Wealth Management Services Inc 143,296 SH137,564 dollarsUnchanged Prior quarter: 143,296Open filing 0001802655-26-000009 Filed 2026-11-09 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 84,940 SH81,542 dollarsUnchanged Prior quarter: 84,940Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
Corient Private Wealth LP 81,287 SH78,036 dollarsHigher by 3,061 Prior quarter: 78,226Open filing 0001948780-26-000012 Filed 2026-11-16 Dispute this row
Voss Capital, LP 71,512 SH68,652 dollarsLower by 103,488 Prior quarter: 175,000Open filing 0001730145-26-000006 Filed 2026-11-16 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager71,065 SH68,222 dollarsNot in the prior quarter’s filings read Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
MORGAN STANLEY Partly reported under another manager68,373 SH65,638 dollarsHigher by 40,500 Prior quarter: 27,873Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
McAdam, LLC 59,004 SH56,644 dollarsLower by 5,549 Prior quarter: 64,553Open filing 0001580642-26-007004 Filed 2026-10-21 Dispute this row
FCA CORP /TX 52,536 SH50,435 dollarsUnchanged Prior quarter: 52,536Open filing 0001104659-26-125595 Filed 2026-11-12 Dispute this row
JONES FINANCIAL COMPANIES LLLP Partly reported under another manager50,661 SH47,419 dollarsHigher by 10,017 Prior quarter: 40,644Open filing 0001193125-26-459442 Filed 2026-11-13 Dispute this row
BlueStem Wealth Partners, LLC 50,000 SH48,000 dollarsNot in the prior quarter’s filings read Open filing 0001765380-26-000496 Filed 2026-11-13 Dispute this row
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management 48,000 SH46,080 dollarsUnchanged Prior quarter: 48,000Open filing 0001085146-26-000916 Filed 2026-10-27 Dispute this row
Lido Advisors, LLC 46,149 SH44,303 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-004854 Filed 2026-11-04 Dispute this row
Bangor Savings Bank Partly reported under another manager40,519 SH38,898 dollarsUnchanged Prior quarter: 40,519Open filing 0001352675-26-000007 Filed 2026-10-06 Dispute this row
Essex Financial Services, Inc. 40,000 SH38,400 dollarsUnchanged Prior quarter: 40,000Open filing 0001951757-26-001932 Filed 2026-11-13 Dispute this row
StoneX Group Inc. Partly reported under another manager30,945 SH29,840 dollarsNot in the prior quarter’s filings read Open filing 0000913760-26-000042 Filed 2026-11-03 Dispute this row
Spark Investment Management LLC 30,200 SH28,992 dollarsNot in the prior quarter’s filings read Open filing 0000899140-26-001312 Filed 2026-11-13 Dispute this row
GABELLI FUNDS LLC 30,000 SH28,800 dollarsUnchanged Prior quarter: 30,000Open filing 0001140361-26-043450 Filed 2026-11-12 Dispute this row
Bryn Mawr Trust Advisors, LLC 29,050 SH27,888 dollarsUnchanged Prior quarter: 29,050Open filing 0001085146-26-000927 Filed 2026-11-04 Dispute this row
CITIZENS FINANCIAL GROUP INC/RI Partly reported under another manager27,358 SH26,264 dollarsHigher by 13,679 Prior quarter: 13,679Open filing 0000759944-26-000210 Filed 2026-10-23 Dispute this row
HighTower Advisors, LLC 26,500 SH25,440 dollarsUnchanged Prior quarter: 26,500Open filing 0001085146-26-000933 Filed 2026-11-10 Dispute this row
PRIVATE MANAGEMENT GROUP INC Partly reported under another manager24,000 SH23,040 dollarsUnchanged Prior quarter: 24,000Open filing 0001142031-26-000022 Filed 2026-11-04 Dispute this row
Vanguard Global Advisers, LLC 23,641 SH22,695 dollarsUnchanged Prior quarter: 23,641Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row
CWA Asset Management Group, LLC Partly reported under another manager23,000 SH22,080 dollarsUnchanged Prior quarter: 23,000Open filing 0001667134-26-000006 Filed 2026-10-19 Dispute this row
Virtu Financial LLC Partly reported under another manager22,742 SH22 dollarsLower by 60,692 Prior quarter: 83,434Open filing 0001533964-26-000015 Filed 2026-11-17 Dispute this row
Creative Planning 22,200 SH21,312 dollarsUnchanged Prior quarter: 22,200Open filing 0001540235-26-000006 Filed 2026-11-02 Dispute this row
XTX Topco Ltd Partly reported under another manager21,022 SH20,181 dollarsLower by 57,449 Prior quarter: 78,471Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row
Cetera Investment Advisers 20,830 SH19,997 dollarsHigher by 980 Prior quarter: 19,850Open filing 0001666741-26-000005 Filed 2026-11-13 Dispute this row
Vestmark Advisory Solutions, Inc. Partly reported under another manager20,080 SH19,276 dollarsHigher by 10,040 Prior quarter: 10,040Open filing 0001172661-26-005184 Filed 2026-11-16 Dispute this row
GAMCO INVESTORS, INC. ET AL 20,000 SH19,200 dollarsUnchanged Prior quarter: 20,000Open filing 0001140361-26-043449 Filed 2026-11-12 Dispute this row
Rockefeller Capital Management L.P. Partly reported under another manager19,231 SH18,462 dollarsUnchanged Prior quarter: 19,231Open filing 0001739439-26-000009 Filed 2026-11-13 Dispute this row
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 17,467 SH16,768 dollarsUnchanged Prior quarter: 17,467Open filing 0001085146-26-000940 Filed 2026-11-13 Dispute this row
Focus Partners Wealth 17,250 SH16,560 dollarsUnchanged Prior quarter: 17,250Open filing 0001542153-26-000021 Filed 2026-11-12 Dispute this row
MERCER GLOBAL ADVISORS INC /ADV Partly reported under another manager15,951 SH15,313 dollarsUnchanged Prior quarter: 15,951Open filing 0000853758-26-000020 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Sixth Street Partners Management Company, L.P. 84,940 SH
  • Circle Wealth Management, LLC 48,842 SH
  • Qube Research Technologies Ltd 21,800 SH
  • Robertson Stephens Wealth Management, LLC 10,000 SH
  • CITIGROUP INC 7,620 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text; they are read only when their rows add up to the totals the filer states.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Institutional ownership reported on Form 13F

13F filers report holding between 7.20% and 23.27% of shares outstanding.

Quarter ending 2026-09-30, against 95,100,822 shares on the cover dated 2026-11-02.

  • The lower figure counts positions a manager reports as its own with sole discretion. The upper figure counts every plain-share position and can count a share twice.
  • Neither includes holders that do not file Form 13F, or managers below the filing threshold.
Quarter-by-quarter 13F holders
QuarterManagers holdingShares, at leastShares, at mostFilings read
2026-09-30 786,847,71322,128,7518,935
2026-06-30 677,232,43022,672,0759,178
2026-03-31 755,750,54521,417,6939,173
2025-12-31 785,954,55421,497,4029,222
2025-09-30 695,716,19521,285,1468,469
2025-06-30 501,543,38811,241,5088,516
2025-03-31 521,818,48411,627,9838,518
2024-12-31 462,352,95111,088,3428,580

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
BIOS MEMORY SPV I, LP Common Stock, par value $0.001 per share1.61,424,014.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS MEMORY SPV II, LP Common Stock, par value $0.001 per share0.4385,248.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS FUND I, LP Common Stock, par value $0.001 per share0.5418,926.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS FUND I QP, LP Common Stock, par value $0.001 per share0.3245,029.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BP DIRECTORS, LP Common Stock, par value $0.001 per share0.0432,328.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS FUND II, LP Common Stock, par value $0.001 per share0.178,298.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS FUND II QP, LP Common Stock, par value $0.001 per share0.3255,765.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS FUND II NT, LP Common Stock, par value $0.001 per share0.0434,238.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS FUND III, LP Common Stock, par value $0.001 per share0.4309,748.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS FUND III QP, LP Common Stock, par value $0.001 per share2.32,021,906.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS FUND III NT, LP Common Stock, par value $0.001 per share0.4326,733.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS CLINICAL OPPORTUNITY FUND, LP Common Stock, par value $0.001 per share0.6500,095.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS EQUITY PARTNERS, LP Common Stock, par value $0.001 per share1.21,081,531.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS EQUITY PARTNERS II, LP Common Stock, par value $0.001 per share0.4368,301.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS EQUITY PARTNERS III, LP Common Stock, par value $0.001 per share3.02,658,387.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS EQUITY COF, LP Common Stock, par value $0.001 per share0.6500,095.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
CAVU MANAGEMENT, LP Common Stock, par value $0.001 per share6.35,532,233.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS CAPITAL MANAGEMENT, LP Common Stock, par value $0.001 per share6.86,032,328.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
CAVU ADVISORS, LLC Common Stock, par value $0.001 per share6.35,532,233.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
BIOS ADVISORS GP, LLC Common Stock, par value $0.001 per share6.86,032,328.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
LESLIE W. KREIS Common Stock, par value $0.001 per share6.35,532,233.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
AARON G.L. FLETCHER Common Stock, par value $0.001 per share6.96,059,555.0009/19/2025 Filed 2025-09-23SCHEDULE 13D/AAmendment 4Open filing 0001104659-25-092675 Dispute this row
AIGH Capital Management, LLC Common Shares4.81,448,270— Filed 2024-02-07SC 13G/AAmendment 2Read from the cover page textOpen filing 0001493152-24-005342 Dispute this row
Orin Hirschman Common Shares4.81,448,270— Filed 2024-02-07SC 13G/AAmendment 2Read from the cover page textOpen filing 0001493152-24-005342 Dispute this row
Pathstone Family Office, LLC Common stock7.532,205,377— Filed 2024-01-19SC 13GRead from the cover page textOpen filing 0001085146-24-000333 Dispute this row
BIOS MEMORY SPV I, LP Common Stock, par value $0.001 per share4.61,424,014— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS MEMORY SPV II, LP Common Stock, par value $0.001 per share1.2385,248— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS FUND I, LP Common Stock, par value $0.001 per share1.4418,926— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS FUND I QP, LP Common Stock, par value $0.001 per share0.8245,029— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS FUND II, LP Common Stock, par value $0.001 per share0.378,298— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS FUND II QP, LP Common Stock, par value $0.001 per share0.8255,765— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS FUND II NT, LP Common Stock, par value $0.001 per share0.134,238— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS FUND III, LP Common Stock, par value $0.001 per share1.0309,748— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS FUND III QP, LP Common Stock, par value $0.001 per share6.52,021,906— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS FUND III NT, LP Common Stock, par value $0.001 per share1.1326,733— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS CLINICAL OPPORTUNITY FUND, LP Common Stock, par value $0.001 per share1.6500,095— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BP DIRECTORS, LP Common Stock, par value $0.001 per share0.026,000— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS EQUITY PARTNERS, LP Common Stock, par value $0.001 per share3.41,055,203— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS EQUITY PARTNERS II, LP Common Stock, par value $0.001 per share1.2368,301— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS EQUITY PARTNERS III, LP Common Stock, par value $0.001 per share8.62,658,387— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS EQUITY COF, LP Common Stock, par value $0.001 per share1.6500,095— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
CAVU MANAGEMENT, LP Common Stock, par value $0.001 per share17.85,505,905— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS CAPITAL MANAGEMENT, LP Common Stock, par value $0.001 per share19.46,006,000— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
CAVU ADVISORS, LLC Common Stock, par value $0.001 per share17.85,505,905— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
BIOS ADVISORS GP, LLC Common Stock, par value $0.001 per share19.46,006,000— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
LESLIE WAYNE KREIS, JR. Common Stock, par value $0.001 per share17.85,505,905— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
AARON GLENN LOUIS FLETCHER Common Stock, par value $0.001 per share19.46,006,000— Filed 2023-11-13SC 13D/AAmendment 3Read from the cover page textOpen filing 0001104659-23-117349 Dispute this row
AIGH Capital Management, LLC Common Shares7.02,037,853— Filed 2023-02-15SC 13G/AAmendment 1Read from the cover page textOpen filing 0001493152-23-005130 Dispute this row
Orin Hirschman Common Shares7.02,037,853— Filed 2023-02-15SC 13G/AAmendment 1Read from the cover page textOpen filing 0001493152-23-005130 Dispute this row
BIOS MEMORY SPV I, LP Common Stock, par value $0.001 per share5.91,424,014— Filed 2022-12-05SC 13D/AAmendment 2Read from the cover page textOpen filing 0001104659-22-124618 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

3,104,499 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015258,595
2016246,472
2017244,814
2018245,575
2019238,619
2020249,093
2021274,850
2022257,922
2023253,676
2024261,106
2025235,525
2026263,830

Filings made before the SEC required XML are listed, not extracted.

Back to Cognition Therapeutics, Inc.